Cantourage Group SE (ETR:HIGH)
3.220
-0.030 (-0.92%)
At close: Jan 23, 2026
Cantourage Group SE Employees
Cantourage Group SE had 7 employees as of June 30, 2025. The number of employees increased by 0 or 3.70% since the number was reported on December 31, 2024.
Employees
7
Change
0
Growth
3.70%
Revenue / Employee
€279,221
Profits / Employee
€13,647
Market Cap
40.15M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 7 | 0 | 3.70% |
| Dec 31, 2024 | 7 | 1 | 8.00% |
| Dec 31, 2023 | 6 | 6 | 2,400.00% |
| Dec 31, 2022 | 0 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Maternus-Kliniken Aktiengesellschaft | 1,426 |
| FamiCord AG | 771 |
| DocCheck AG | 373 |
| MeVis Medical Solutions AG | 100 |
Cantourage Group SE News
- 5 weeks ago - Cantourage Group SE Projects 2025 EBITDA to Surpass Market Expectations - Wallstreet:Online
- 5 weeks ago - EQS-Adhoc: Cantourage Group SE expects EBITDA for 2025 to exceed current market expectations based on preliminary figures - Wallstreet:Online
- 2 months ago - EQS-News: Cantourage strengthens market presence in Poland with flower variety “Gelato 33” - Wallstreet:Online
- 3 months ago - Cantourage Group Thrives in Q3 2025 Amid Regulatory Challenges - Wallstreet:Online
- 3 months ago - EQS-News: Q3 2025: Cantourage delivers strong operating performance in a challenging regulatory market environment - Wallstreet:Online
- 3 months ago - EQS-News: Cantourage is responding to potential developments resulting from new legal regulations with focused internationalization and strategic product diversification - Wallstreet:Online
- 4 months ago - EQS-News: Cantourage Strengthens Capital Markets Presence: New Head of Investor Relations and Strategic Focus on Europe - Wallstreet:Online
- 4 months ago - EQS-DD: Cantourage Group SE: Philip Schetter, Acquisition of 188,639 Shares as Part of a Capital Increase Against Contributions in Kind, Excluding Subscription Rights, at an Issue Price of EUR ... - Wallstreet:Online